Metachronous gonadal and extragonadal primacies, or late relapse of germ cell tumor?

被引:12
作者
Daniel, C
Fizazi, K
Culine, S
Zelek, L
Wibault, P
Theodore, C
机构
[1] Inst Gustave Roussy, Dept Med, F-94805 Villejuif, France
[2] Inst Gustave Roussy, Dept Radiotherapy, F-94805 Villejuif, France
来源
UROLOGIC ONCOLOGY | 2001年 / 6卷 / 02期
关键词
germ cell tumor; testis; extragonadal germ cell tumor; late relapse; genetic predisposition;
D O I
10.1016/S1078-1439(00)00091-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We report five distinct cases of apparently metachronous extragonadal and gonadal germ cell tumors (GCT) occurring in the same patient. Two patients had metachronous GCT of the central nervous system and the testis. One of these patients had been successfully treated for a germinoma of the pineal gland and developed a nonseminomatous GCT of the testis 10 years later. The second patient had a primary seminoma of the testis treated by orchiectomy followed by radiotherapy and developed a germinoma of the sphenoidal sinus 17 months later. Three other patients had an apparently metachronous retroperitoneal and testicular GCT with 22, 44. and 66 months elapsing, respectively, between the first and second neoplasms. These cases suggest that the remaining testis is not only at risk for a second primary GCT, but that a second GCT may emerge at an extragonadal site. A genetic predisposition may account for some of these cases and the occurrence of bilateral testicular GCT. In none of these cases, however, could we ascertain whether testicular GCT was truly a second primary or a relapse of a "primary" retroperitoneal GCT in our cases. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:49 / 52
页数:4
相关论文
共 49 条
[1]  
AZZOPARDI J, 1961, AM J PATHOL, V38, P207
[2]   LATE RELAPSE OF TESTICULAR CANCER [J].
BANIEL, J ;
FOSTER, RS ;
GONIN, R ;
MESSEMER, JE ;
DONOHUE, JP ;
EINHORN, LH .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (05) :1170-1176
[3]   PRIMARY OR SECONDARY EXTRAGONADAL GERM-CELL TUMORS [J].
BOHLE, A ;
STUDER, UE ;
SONNTAG, RW ;
SCHEIDEGGER, JR .
JOURNAL OF UROLOGY, 1986, 135 (05) :939-943
[4]   RISK OF SECONDARY LEUKEMIA FOLLOWING HIGH CUMULATIVE DOSES OF ETOPOSIDE DURING CHEMOTHERAPY FOR TESTICULAR CANCER [J].
BOKEMEYER, C ;
SCHMOLL, HJ ;
KUCZYK, MA ;
BEYER, J ;
SIEGERT, W .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (01) :58-60
[5]   TREATMENT OF TESTICULAR CANCER AND THE DEVELOPMENT OF SECONDARY MALIGNANCIES [J].
BOKEMEYER, C ;
SCHMOLL, HJ .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (01) :283-292
[6]   BILATERAL TESTICULAR-TUMORS - PREVALENCE AND CLINICAL IMPLICATIONS [J].
BOKEMEYER, C ;
SCHMOLL, HJ ;
SCHOFFSKI, P ;
HARSTRICK, A ;
BADING, M ;
POLIWODA, H .
EUROPEAN JOURNAL OF CANCER, 1993, 29A (06) :874-876
[7]  
BURT ME, 1981, CANCER-AM CANCER SOC, V47, P1911, DOI 10.1002/1097-0142(19810401)47:7<1911::AID-CNCR2820470732>3.0.CO
[8]  
2-J
[9]  
COLLINS DH, 1984, BR J UROL, V36, P1
[10]  
Coogan CL, 1998, CANCER, V83, P547, DOI 10.1002/(SICI)1097-0142(19980801)83:3<547::AID-CNCR24>3.0.CO